Who Should be Started on a Cholinesterase Inhibitor? A ChEI is an option for most people with mild to moderate AD (the commonly seen behavioural signs of this phase of AD are shown in Table 1).

Background Activities of daily living (ADL) are an essential part of the diagnostic criteria for Alzheimer's disease (AD ... Functional response to cholinesterase inhibitor (ChEI) treatment ...

One of these chemicals is called acetylcholine. When a person has Alzheimer’s disease or dementia with Lewy bodies, they have less acetylcholine. This means that their nerve cells lose the ability to ...

Amyloid-β (Aβ)-rich plaques and tau-containing neurofibrillary tangles are neuropathological hallmarks of Alzheimer's disease (AD). Currently approved drugs for AD target cholinesterase ...

A landmark study examining over 3.4 million brain cells has revealed that Alzheimer’s disease progresses through two distinct ...

Lewy body disease (LBD), which includes dementia with Lewy bodies (DLB) and Parkinson’s disease with or without dementia, is ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...